Literature DB >> 8005123

Gradient-echo magnetic resonance imaging during incremental dobutamine infusion for the localization of coronary artery stenoses.

F M Baer1, E Voth, P Theissen, H Schicha, U Sechtem.   

Abstract

Dobutamine pharmacological stress testing in conjunction with gradient-echo magnetic resonance imaging (MRI) may be a useful tool for the assessment of haemodynamically significant coronary artery stenoses. Therefore, 28 patients without previous myocardial infarction but significant proximal stenoses (> or = 70% diameter stenosis) of one or more coronary arteries were selected for dobutamine-MRI. Each patient underwent MRI at rest and during incremental dobutamine infusion (5, 10, 15 and 20 micrograms.kg-1.min-1). Additionally, all patients were submitted to exercise stress electrocardiography (EST). A total of 72 segments per patient obtained from identical short axis and transverse tomograms at rest and during dobutamine infusion were evaluated by two observers. Each segment was graded as normal, hypokinetic, akinetic or dyskinetic. Dobutamine-MRI was considered pathological if segmental wall motion deteriorated by at least one grade after dobutamine infusion. For comparison with coronary angiography, segmental wall motion gradings were related to the respective coronary artery territories. Peak rate-pressure product during steady-state dobutamine infusion (18.493 +/- 4.315 mmHg.min-1) was significantly lower (P < 0.01) than during EST (21.316 +/- 4.937 mmHg.min-1). Dobutamine-induced wall motion abnormalities were observed in 22/26 (85%) MR studies and 20/26 (77%) patients had a pathological EST. Regional asynergy induced by dobutamine-MRI occurred in 11/15 (73%) patients with single and 11/11 (100%) with multi-vessel disease. Sensitivity and specificity for the detection of a stenosed coronary artery were 87% and 100% for the left anterior descending, 62% and 93% for the left circumflex and 78% and 88% for the right coronary artery respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8005123     DOI: 10.1093/oxfordjournals.eurheartj.a060479

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  9 in total

Review 1.  Magnetic resonance imaging in detection and functional assessment of coronary artery disease.

Authors:  Wojciech Mazur; Steffen Brucks; Stephen N Darty; Pairoj Rerkpattanapipat
Journal:  Curr Atheroscler Rep       Date:  2002-03       Impact factor: 5.113

Review 2.  Ischemic heart disease: value of MR techniques.

Authors:  E E van der Wall; F P van Rugge; H W Vliegen; J H Reiber; A de Roos; A V Bruschke
Journal:  Int J Card Imaging       Date:  1997-06

Review 3.  MR of acquired heart disease: ischemic heart disease.

Authors:  A E Stillman
Journal:  Int J Cardiovasc Imaging       Date:  2001-12       Impact factor: 2.357

Review 4.  Left main coronary artery disease: A review of the spectrum of noninvasive diagnostic modalities.

Authors:  Nishtha Sareen; Karthik Ananthasubramaniam
Journal:  J Nucl Cardiol       Date:  2015-10-20       Impact factor: 5.952

5.  Myocardial viability assessment in patients with highly impaired left ventricular function: comparison of delayed enhancement, dobutamine stress MRI, end-diastolic wall thickness, and TI201-SPECT with functional recovery after revascularization.

Authors:  M Gutberlet; M Fröhlich; S Mehl; H Amthauer; H Hausmann; R Meyer; H Siniawski; J Ruf; M Plotkin; T Denecke; B Schnackenburg; R Hetzer; R Felix
Journal:  Eur Radiol       Date:  2005-03-08       Impact factor: 5.315

6.  Serial assessment of left ventricular function during dobutamine stress by means of electrocardiography-gated myocardial SPECT: combination with dual-isotope myocardial perfusion SPECT for detection of ischemic heart disease.

Authors:  S Kumita ; K Cho; H Nakajo; M Toba; T Kijima; S Mizumura; T Oshina; T Kumazaki; J Sano; K Sakurai; K Munakata
Journal:  J Nucl Cardiol       Date:  2001 Mar-Apr       Impact factor: 5.952

Review 7.  Magnetic resonance imaging in the evaluation of non-ischemic cardiomyopathies: current applications and future perspectives.

Authors:  Ilan Gottlieb; Robson Macedo; David A Bluemke; João A C Lima
Journal:  Heart Fail Rev       Date:  2006-12       Impact factor: 4.214

8.  Parallel imaging and dobutamine stress magnetic resonance imaging in patients with atypical chest pain or equivocal ECG not suitable for stress echocardiography.

Authors:  E Di Cesare; S Battisti; A Riva; C Corbacelli; G De Bernardinis; S Cicogna; C Masciocchi
Journal:  Radiol Med       Date:  2009-03-05       Impact factor: 3.469

9.  Cardiac functional stress imaging: a sequential approach with stress echo and cardiovascular magnetic resonance.

Authors:  Rosa Sicari; Alessandro Pingitore; Giovanni Aquaro; Emilio G Pasanisi; Massimo Lombardi; Eugenio Picano
Journal:  Cardiovasc Ultrasound       Date:  2007-12-04       Impact factor: 2.062

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.